Neurol. praxi. 2009;10(1):13-18

Pathophysiology and therapeutic options of intracranial hypertension

MUDr. Miroslav Kalina
Neurologické oddělení Nemocnice Na Homolce, Praha

Intracranial hypertension has a number of causes with converging mechanisms of secondary brain damage. Vascular autoregulation,

blood-brain barrier disruption, membrane depolarization, biochemical cascade with glutamate and free radicals´ effects, and mechanisms

of interstitial and intracellular edema are analysed. Common and specific therapeutic measures based on these pathophysiological

processes are derived: complex monitoring including intracranial pressure, cerebral perfusion pressure control, sedation, analgesia,

therapeutic hyperventilation, barbiturate coma, external ventricular drainage, decompressive craniectomy with focus on new indications

in malignant ischemic stroke in the middle cerebral artery territory.

Keywords: intracranial hypertension, secondary cerebral damage, cerebral oedema, vascular autoregulation, cerebral perfusion pressure, external ventricular drainage, decompressive craniectomy, malignant infarction.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalina M. Pathophysiology and therapeutic options of intracranial hypertension. Neurol. praxi. 2009;10(1):13-18.
Download citation

References

  1. Adams HP, et al. Guidelines for the Early Management of Adults With Ischemic Stroke. Stroke 2007; 38: 1655-1711. Go to original source... Go to PubMed...
  2. Chen HI, Malhotra NR, Oddo M, et al. Barbiturate infusion for intractable intracranial hypertension and its effect on brain oxygenation. Neurosurgery 2008 Nov; 63(5): 880. Go to original source... Go to PubMed...
  3. Foerch Ch, et al. Serum S100B Predicts a Malignant Course of Infarction in Patients With Acute Middle Cerebral Artery Occlusion Stroke. 2004; 35: 2160-2164. Go to original source... Go to PubMed...
  4. Octavio M, et al. High Serum Levels of Endothelin-1 Predict Severe Cerebral Edema in Patients With Acute Ischemic Stroke Treated With t-PA, Stroke. 2008; 39: 2006. Go to original source... Go to PubMed...
  5. Serena J, et al. The Prediction of Malignant Cerebral Infarction by Molecular Brain Barrier Disruption Markers Stroke. 2005; 36: 1921. Go to original source... Go to PubMed...
  6. Schwab S, et al. Early Hemicraniectomy in Patients With Complete Middle Cerebral Artery Infarction, Stroke. 1998; 29: 1888-1893. Go to original source... Go to PubMed...
  7. Thanvi B, et al. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management, Postgrad. Med. J. 2008; 84: 412-417. Go to original source... Go to PubMed...
  8. The Brain Trauma Foundation. The Joint Section on Neurotrauma and Critical Care. Guidelines for the Management of Severe Traumatic Brain Injury. J. Neurotrauma 2007; 24: Suppl. 1.
  9. Vahedi K, Hofmeijer J, Juettler E, et al. For the decimal, destiny, and hamlet investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215-222. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.